MARKET

TARO

TARO

Taro Pharm
NYSE

Real-time Quotes | Nasdaq Last Sale

71.50
-0.51
-0.71%
After Hours: 71.50 0 0.00% 16:00 03/03 EST
OPEN
72.38
PREV CLOSE
72.01
HIGH
73.57
LOW
71.32
VOLUME
36.99K
TURNOVER
--
52 WEEK HIGH
80.00
52 WEEK LOW
53.95
MARKET CAP
2.74B
P/E (TTM)
-9.0378
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Lidocaine Market Size Global Industry Share, Revenue, Growth, Development, Business Opportunities 2021, Trends, Top Key Players and Global Analysis Forecast to 2026
Mar 03, 2021 (The Expresswire) -- “Final Report will add the analysis of the impact of COVID-19 on this industry." “ Lidocaine Market” global industry...
The Express Wire · 14h ago
Impetigo Treatment Market Growth, Share, Size, Global 2021 Emerging Technologies, COVID-19 Impact on Industry Trends, Segments, Demand, Competitors, Regional and Forecast to 2026
Feb 25, 2021 (The Expresswire) -- Global "Impetigo Treatment Market" (2021) thoroughly scrutinizes the effects of a wide range of factors impacting the...
The Express Wire · 6d ago
Levocetirizine Drug Market Outlook, Opportunity and Demand Analysis Forecast 2021 - 2026
Market Insight Reports · 02/24 12:14
Global Enalapril Market Share 2021 CAGR Value, Top Companies, Growth Factors, Industry Size, Classification, Regional Analysis, Development Factors and Forecast to 2026
Feb 24, 2021 (The Expresswire) -- Global “Enalapril Market” research report provides important information related to the overall market and price forecast...
The Express Wire · 02/24 08:01
Mouth Ulcers Drugs Market Research Report by Type, by Product, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19
Feb 23, 2021 (Heraldkeepers) -- The global Mouth Ulcers Drugs market report provides geographic analysis covering regions, such as North America, Europe,...
Heraldkeepers · 02/23 15:41
Nasal Polyps Treatment Market to see Huge Growth by 2025 | OptiNose, Merck, Pfizer, Sanofi
Feb 22, 2021 (Market Insight Reports) -- Latest released the research study on Global Nasal Polyps Treatment Market, offers a detailed overview of the...
Market Insight Reports · 02/22 12:12
Urticaria Drug Market Analysis, Trends and CAGR Projections 2020-2027 |Ameco Research
pune, India, Mon, 22 Feb 2021 04:59:25 / Comserve Inc. / -- Urticaria is commonly known as rubella. It is a localized edema response due to dilation of the...
Comserve · 02/22 10:01
Econazole Nitrate Cream Market Size, Global Strategic Analysis, Revenue Opportunities, Share, Emerging Technologies, Sales, Revenue, Key Players Analysis, Development Status, Growth, Drivers | Forecast 2021-2027
Feb 22, 2021 (The Expresswire) -- Global "Econazole Nitrate Cream Market" Research Report features an extensive study of the current market landscape and...
The Express Wire · 02/22 07:52
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TARO. Analyze the recent business situations of Taro Pharm through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TARO stock price target is 81.00 with a high estimate of 81.00 and a low estimate of 81.00.
EPS
Institutional Holdings
Institutions: 154
Institutional Holdings: 5.50M
% Owned: 14.36%
Shares Outstanding: 38.26M
TypeInstitutionsShares
Increased
26
456.19K
New
27
-18.63K
Decreased
23
257.39K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-1.00%
Pharmaceuticals & Medical Research
-1.98%
Key Executives
Chairman/Director
Dilip Shanghvi
Chief Executive Officer/Director
Uday Baldota
Vice Chairman/Director
Abhay Gandhi
Chief Financial Officer/Chief Accounting Officer/Vice President
Daphne Huang
Vice President/General Counsel/Secretary
Erik Zwicker
Vice President/Director of Human Resources
Michele Visosky
Vice President
Richard Glaze
Vice President
Ori Gutwerg
Vice President
Itamar Karsenti
Vice President
Chantal LeBlanc
Vice President - Research & Development
Avi Avramoff
Other
Jayesh Shah
Director
James Kedrowski
Director
Sudhir Valia
Independent Director
Linda Benshoshan
Independent Director
Dov Pekelman
Independent Director
Robert Stein
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
11/05/2018
Dividend USD 0
12/10/2018
11/05/2018
Special Dividend USD 12.81
12/10/2018
  • All
  • Financials
  • Insiders
More
About TARO
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.

Webull offers kinds of Taro Pharmaceutical Industries Ltd. stock information, including NYSE:TARO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TARO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TARO stock methods without spending real money on the virtual paper trading platform.